Profile:
Kyowa Kirin is a global specialty pharmaceutical company dedicated to developing new drugs and antibody technologies to enhance human life. BioWa, a member of the Kyowa Kirin Group, is committed to advancing life science through antibody-based technologies, including third party licensing. ProStrakan, a subsidiary of Kyowa Kirin, is dedicated to commercializing specialty pharmaceuticals that address the unmet needs of patients with cancer and the healthcare professionals who care for them.

Categories

Biotechnology

Cancer/Chemotherapy

Human Biologicals

Immunotherapy

Monoclonal Antibodies

Oncology Pharmaceuticals

Pharmaceuticals